Ganga Pharmaceuticals Reports Half-Year Financial Results for Period Ended Sep'26
Ganga Pharmaceuticals Ltd · Financial Result · 02 Nov 2026, 10:21 pm
Ganga Pharmaceuticals Reports Half-Year Financial Results for Period Ended Sep'26 Ganga Pharmaceuticals posted revenue from operations of ₹141.63 lakhs for the half year ended 30th Sep'26, up 3.64% YoY from ₹136.65 lakhs. Total income reached ₹155.27 lakhs compared to ₹146.91 lakhs in the prior-year period. Net profit declined 66.18% YoY to ₹1.86 lakhs versus ₹5.50 lakhs, pressured by total expenses rising to ₹152.76 lakhs from ₹144.16 lakhs. Profit before tax stood at ₹2.52 lakhs, down from ₹3.35 lakhs YoY. Diluted EPS for the half-year period came in at ₹0.03.
Original exchange filing (PDF)
More announcements from Ganga Pharmaceuticals Ltd
- Outcome of the Board Meeting pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 held on Monday, November 02, 2026 · 02 Nov 2026
- Ganga Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2026 ,inter alia, to consider and approve inter-alia, the Un-audited .... · 02 Nov 2026
- Re-appointment of Managing Director · 27 Sept 2026
- Voting Results of 37th Annual General Meeting along with the Scrutinizer Report · 27 Sept 2026
- Proceeding of the AGM held on Saturday, September 26, 2026 · 27 Sept 2026
- The Company has sent Letter to the Shareholder for aGM whose Email Id is not resgistered with the RTA · 02 Sept 2026
- Please find enclosed herewith the Notice of the AGM for F.Y. 2025-26 · 02 Sept 2026
- Please find enclosed herewith the Annual Report for F.Y. 2025-26 · 02 Sept 2026
